Delivery Order SPE2DB22D1103-SPE2DB25FTPA3

Award Date 6/4/25
Potential Completion Date 6/5/25
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TLANDO 112.5 MG CAPSULE 120S medical products. The contract has a ceiling value of $1,011.22 and a completion date of April 3, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,729.49, is for the delivery of 120 units of the drug TLANDO 112.5 MG CAPSULE. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 19, 2023. The contract does not have a set-aside designation, indicating it was competitively awarded. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,374.91, is for the delivery of TLANDO 112.5 MG CAPSULE 120S, a pharmaceutical product, with a completion date of February 29, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,233.81 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 120 capsules of the pharmaceutical product TLANDO 112.5 MG. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical. The IDC allows DLA to efficiently procure...
This federal contract award is for the delivery of TLANDO 112.5 MG CAPSULE 120S to the Defense Logistics Agency (DLA). The contract, valued at $1,516.83, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a completion date of March 20, 2025. The award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TLANDO 112.5 MG CAPSULE 120S, with an ultimate completion date of May 30, 2025 and a ceiling value of $1,011.22. The contract is not set-aside and is for the supply of a pharmaceutical product to the DLA, which is the funding federal agency. Amerisourcebergen...
This federal contract award is for the delivery of TLANDO 112.5 MG CAPSULE 120S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,289.36, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 23, 2024. There is no set-aside designation...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of medical products and supplies. The contract, valued at $597,775.17, has an ultimate completion date of October 31, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
The U.S. Department of Defense agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed-price delivery order contract valued at $1,298.76 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply a variety of pharmaceutical products and medical supplies. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, to provide a wide range of medical supplies and prescription drugs. The $1,099.20 firm fixed price contract has an ultimate completion date of August 28, 2024. This order is likely part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that the DLA Troop Support...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB25FTPA3
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, is for the delivery of TLANDO 112.5 MG CAPSULE 120S, a medical product. The contract has a firm fixed price of $1,011.22 and an ultimate completion date of June 5, 2025. The award was made on June 4, 2025, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/3/25, 9:48 AM